Free Trial

Pharma-Bio Serv Q2 2023 Earnings Report

Pharma-Bio Serv logo
$0.58 0.00 (0.00%)
As of 01/21/2025

Pharma-Bio Serv EPS Results

Actual EPS
$0.02
Consensus EPS
$0.02
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Pharma-Bio Serv Revenue Results

Actual Revenue
$4.56 million
Expected Revenue
$5.00 million
Beat/Miss
Missed by -$440.00 thousand
YoY Revenue Growth
N/A

Pharma-Bio Serv Announcement Details

Quarter
Q2 2023
Time
After Market Closes

Conference Call Resources

Pharma-Bio Serv Earnings Headlines

Pharma-Bio Serv (PBSV) Projected to Post Quarterly Earnings on Monday
Donald Trump is about to free crypto from its chains …
With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.
PBSV Makes Progress on Improvements
Pharma-Bio Serv Inc PBSV
See More Pharma-Bio Serv Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pharma-Bio Serv? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pharma-Bio Serv and other key companies, straight to your email.

About Pharma-Bio Serv

Pharma-Bio Serv (OTCMKTS:PBSV) operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

View Pharma-Bio Serv Profile

More Earnings Resources from MarketBeat